Your shopping cart is currently empty

OBAA is a phospholipase inhibitor and a broad-spectrum PLA2 inhibitor. It exhibits potent anti-inflammatory activity by blocking arachidonic acid pathways, used for acute inflammation research.


| Description | OBAA is a phospholipase inhibitor and a broad-spectrum PLA2 inhibitor. It exhibits potent anti-inflammatory activity by blocking arachidonic acid pathways, used for acute inflammation research. |
| Targets&IC50 | PLA2:70 nM |
| In vitro | OBAA (5.7 uM) induces apoptosis in HUVECs and regulates Ca2+ entry in T. brucei via PLA2 inhibition [1][2]. |
| In vivo | Intravenous OBAA (2.5-7 mg/kg) significantly inhibits immunologically induced bronchospasm in guinea pig models [3]. |
| Molecular Weight | 428.65 |
| Formula | C28H44O3 |
| Cas No. | 221632-26-4 |
| Smiles | C(CCCCCCCCCCCCCCCCC)C1=CC=C(C(/C=C/C(O)=O)=O)C=C1 |
| Relative Density. | 0.976 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 20 mg/mL (46.66 mM), Sonication is recommmended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.